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ABSTRACT
Background Serum oxalate levels suddenly increase with certain dietary exposures or ethylene glycol
poisoning and are a well known cause of AKI. Established contributors to oxalate crystal–induced renal
necroinflammation include the NACHT, LRR and PYD domains-containing protein-3 (NLRP3) inflamma-
some andmixed lineage kinase domain-like (MLKL) protein–dependent tubule necroptosis. These studies
examined the role of a novel form of necrosis triggered by altered mitochondrial function.
Methods To better understand the molecular pathophysiology of oxalate-induced AIK, we conducted in
vitro studies in mouse and human kidney cells and in vivo studies in mice, including wild-type mice and
knockout mice deficient in peptidylprolyl isomerase F (Ppif) or deficient in both Ppif and Mlkl.
Results Crystals of calcium oxalate, monosodium urate, or calcium pyrophosphate dihydrate, as well as silica
microparticles, triggered cell necrosis involving PPIF–dependentmitochondrial permeability transition. This pro-
cess involves crystal phagocytosis, lysosomal cathepsin leakage, and increased release of reactive oxygen spe-
cies.Micewithacuteoxalosisdisplayedcalciumoxalatecrystals insidedistal tubularepithelial cells associatedwith
mitochondrial changes characteristic of mitochondrial permeability transition. Mice lacking Ppif or Mlkl or given
an inhibitor of mitochondrial permeability transition displayed attenuated oxalate-induced AKI. Dual genetic
deletionofPpif andMlklor pharmaceutical inhibition of necroptosiswas partially redundant, implying interlinked
roles of these two pathways of regulated necrosis in acute oxalosis. Similarly, inhibition of mitochondrial perme-
ability transition suppressed crystal-induced cell death in primary human tubular epithelial cells. PPIF and phos-
phorylated MLKL localized to injured tubules in diagnostic human kidney biopsies of oxalosis-related AKI.
ConclusionsMitochondrial permeability transition–related regulated necrosis and necroptosis both contrib-
ute to oxalate-induced AKI, identifying PPIF as a potential molecular target for renoprotective intervention.
JASN 30: ccc–ccc, 2019. doi: https://doi.org/10.1681/ASN.2018121218
Crystal nephropathies are forms of AKI or CKD
induced by solid particles of various sizes and
shapes composed of atoms, ions, or biomole-
cules.1,2 Crystal nephropathies can be categorized
in three types depending from the localization of
the crystals inside afferent blood vessels (type 1),
inside the nephron (type 2), or inside the renal pel-
vis and ureter (type 3).1 Acute oxalosis is a paradig-
matic form of a type 2 crystal–induced AKI that
occurs upon incident exposures to oxalate-rich
food or drinks, vitamin C supplements, and during
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ethylene glycol poisoning.3–5 Increased intestinal adsorbtion
of oxalate, e.g., after bypass surgeries, can contribute to sec-
ondary hyperoxaluria.6 In acute oxalosis, calcium oxalate
monohydrate and bihydrate (CaOx) crystals form in the distal
tubule. They grow to crystal plugs that obstruct the tubular
lumen in some nephrons but are also widely taken up into
tubular epithelial cells and even reach the interstitial space.1
We recently described that CaOx crystals trigger renal inflam-
mation via the NLRP3 inflammasome- and caspase-1–medi-
ated secretion of IL-1b in intrarenal dendritic cells,7 a process
largely contributing to AKI. We subsequently described that
crystals also exert a direct cytotoxic effect on tubular cells in
acute oxalosis by inducing necroptosis, a receptor-interacting
serine-threonine kinase-3 (RIPK3)–dependent and mixed
lineage kinase domain-like (MLKL)–dependent form of reg-
ulated tubular cell necrosis.8 However, genetic deletion or
pharmaceutic inhibition of necroptosis only partially abro-
gated cytotoxicity of CaOx crystals. We hypothesized that an-
other of the recently identified forms of regulated cell death9
could be involved in CaOx crystal–induced AKI and specu-
lated on mitochondrial permeability transition (MPT)–re-
lated cell necrosis,9,10 because a suitable inhibitor was previ-
ously shown to limit renal cell death in a rat model of oxalate
nephropathy.11 This pathway is characterized by mitochon-
drial dysfunction involving a peptidylprolyl isomerase F
(PPIF; also named cyclophilin D/F)-driven formation and
permanent opening of the MPT pore, disruption of the mito-
chondrial outer membrane potential, mitochondrial swelling,
loss of cristae, and potentially the release of reactive oxygen
species (ROS) into the cytosol.9,10,12 Indeed, our studies pro-
pose MPT in concert with necroptosis promote cytotoxicity
of CaOx and numerous other crystals, implying MPT/nec-
roptosis as molecular targets to limit CaOx crystal–induced
AKI.
METHODS
Cell Culture Studies
Murine L929 cells were maintained in DMEM/F12 (GIBCO,
Invitrogen, Carlsbad, CA) containing 10% FCS and 1% pen-
icillin-streptomycin. Primary tubular epithelial cells
were isolated from kidneys of Ppifd+/+ and Ppifd2/2 mice
(original strain Ppiftm1Jmol/J, Jackson Laboratories stock no.
009071) and were maintained in DMEM/F12 containing
10% FCS, 1% penicillin-streptomycin, 125 ng/ml PG E1
(Calbiochem, Darmstadt, Germany), 25 ng/ml EGF, 1.8 mg/ml
l-thyroxine, 3.38 ng/ml hydrocortisone, and 2.5 mg/ml of in-
sulin-transferrin-sodium selenite supplement (all from Sigma-
Aldrich, Munich, Germany unless mentioned). Human renal
progenitor cells were prepared from human kidney tissues us-
ing standard sieving technique through graded mesh screens
(60, 80, 150, and 200 mesh).13 Cells were grown to confluence
before use in experiments. Human kidney cells (HK-2) were
maintained in RPMI (GIBCO, Invitrogen) containing 10%
FCS and 1% penicillin-streptomycin. The cell lines, originally
from American Type Culture Collection, were kindly provided
by Peter Nelson (HK-2) and Bruno Luckow (L929), both from
Ludwig Maximilian University (Munich, Germany). All cell
lines used were tested for mycoplasma contamination before
use. All cells were stimulated with crystals of CaOx (1000mg/ml,
1–2 mm size) (Alfa aesar, Karlsruhe, Germany), silica
(500 mg/ml, 1–5 mM size) (Alfa aesar), monosodium urate
(MSU; 1000 mg/ml, 25–125 nm size) (Invivogen, Toulouse,
France), and calcium pyrophosphate dihydrate (CPPD;
500 mg/ml, 25–125 nm size) (Invivogen) in different experi-
ments. Whenever required, 30 minutes before crystal stimula-
tions cells were pretreated with theMPT inhibitor cyclosporine
A (Sigma-Aldrich (0.5 and 1 mm), mitochondrial ROS inhib-
itor (2R, 4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC;
Sigma-Aldrich) (100 and 200 mM), phagocytosis (actin-
polymerization) inhibitor cytochalasin D (Calbiochem) (5 and
10 mM), and cathepsin inhibitor CA074Me (Calbiochem) (10
and 20mM). All the cells were cultured in an incubator at 37°C,
5% CO2. Mitochondrial outer membrane potential and ROS
production were measured using tetramethylrhodamine ethyl
ester (TMRE; Invitrogen), lysotracker (Abcam, Cambridge,
UK), and dichlorofluorescin diacetate (DCFDA) dyes
(Sigma-Aldrich), respectively, according to the manufacturer’s
protocol. Calcein (Invitrogen) was used to identify live cells,
whereas propidium iodide (Invitrogen) was used to identify
dead cells according to the manufacturer’s protocol. Fluores-
cence signals were detected using Leica fluorescence micro-
scope (Leica, Wetzlar, Germany), and quantified using ImageJ
software. In addition, cell deathwas also evaluated using lactate
dehydrogenase cell cytotoxicity assay kit (Roche, Mannheim,
Germany) according to manufacturer’s protocol.
Serial Block Face Scanning Electron Microscopy Data
Collection and Reconstruction
Kidney cells were fixed as above but stained using an enhanced
staining protocol.14 Stained and dehydrated specimens were
embedded into Durcupan ACM resin (Merck, Sigma-Aldrich)
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that was mixed according to the manufacturer’s recommen-
dations. The embedded tissue was trimmed to a pyramid and
mounted onto a pin using conductive epoxy glue (model 2400;
CircuitWorks, Kennesaw, GA). Finally, the sides of the pyra-
mid were covered with silver paint (Agar Scientific Ltd., Stans-
ted, UK), and the whole assembly was platinum coated using
Quorum Q150TS (Quorum Technologies, Laughton, UK).
Serial block face-scanning electronmicroscopy (SB-EM) data-
sets were acquired with an FEG-SEM Quanta 250 (Thermo
Fisher Scientific, FEI, Hillsboro, OR), using a backscattered
electron detector (Gatan Inc., Pleasanton, CA) with 2.5-kV
beam voltage, a spot size of 3, and a pressure of 0.2 Torr.
The block faces were cut with 30-nm increments and imaged
with XY resolution of 22 nm per pixel. The collected 16-bit
images were processed for segmentation using an open-source
software Microscopy Image Browser15 as follows: (1) individual
images were combined into three-dimensional (3D) stacks, (2)
the combined 3D stack was aligned, (3) the contrast for the
whole stack was normalized, and (4) the images were converted
to the eight-bit format. The collected dataset was cropped to
include only cells containing crystals. The cropped dataset was
filtered using BM3D filter16 and segmented using the semiauto-
matic graphcut segmentation of MIB. The graphcut segmenta-
tion starts with clustering of voxels into 3D supervoxels using the
watershed17 (nucleus) or SLIC18 (crystals and cell body) algo-
rithms. An adjacency map of supervoxels with energy barriers
required to travel from one supervoxel to another is calculated
and these values are used to generate a mathematical graph.
Using the provided seeds for background and each aforemen-
tioned organelles, the algorithm performsmaxflow/mincut split
of the graph19 to generate the model. The final visualization of
the model was done in Amira (Thermo Fisher Scientific).
Animal Studies
Ppifd2/2mice were purchased from The Jackson Laboratories
(stock no. 009071) and backcrossed to the C57BL/6J mice
background. J. Murphy and W. Alexander (WEHI, Australia)
kindly provided Mlkl2/2 mice.20 Wild-type mice were pur-
chased from Charles River. All mice were housed in groups of
five under specific pathogen-free and 12-hour light/dark cycle
conditions with ad libitum access to food and water. To induce
acute oxalate nephropathy, 6- to 8-week-old male mice
received a single intraperitoneal injection of 100 mg/kg
of sodium oxalate (Santa Cruz Biotechnology, Heidelberg,
Germany) and 3% sodium oxalate in drinking water and kid-
neys were harvested after 24 hours (n=5–9 per group).7,8 As a
therapeutic strategy, mice received a single dose of either
cyclosporine A (2 mg/kg, administered intravenously;
Sigma-Aldrich) or necrostatin-1s (1.65 mg/kg, administered
intraperitoneally; Millipore, Darmstadt, Germany) or combi-
nation before sodium oxalate injections (n=5–9 per group).
Mice were euthanized by cervical dislocation after collecting
blood and urine. One part of the kidneys was stored in RNA
later solution at220°C for RNA isolation. Another part of the
kidney was stored in formalin to be embedded in paraffin for
histologic analysis. Samples for electron microscopy were
fixed in 4% glutaraldehyde. Mice were assigned different
groups with the use of stratified randomization method. The
local institutional animal ethics committee and government
authorities (Regierung der Oberbayern) approved all experi-
mental procedures. Humane end points, as in the ethical
approval for the study, were monitored throughout the study.
All animal studies were conducted according to the European
equivalent of the National Institutes of Health’s Guide for the
Care and Use of Laboratory Animals.
Human Samples
Aretrospective search forCaOxdeposits in adatabaseof 92,000
medical and transplant renal biopsy specimens (Arkana Lab-
oratories, Little Rock, AR)was performed (institutional review
board approval number 05–4397–0). Paraffin sections were
randomly selected from native kidney biopsy specimens
with adequate residual tissue containing CaOx crystals
(n=20), and stained with 1:500 rabbit anti pMLKL
(#EPR9514; Abcam) and 1:100 rabbit anti CypD (LLC
#NBP2–15079; Novus Biologicals, Littleton, CO) as per man-
ufacturer’s instructions. Antigens were retrieved using citrate
buffer pH 6.0. Bound primary antibody was visualized with a
standard horseradish peroxidase detection system in brown.
Statistical Analyses
Data are presented as mean6SEM. A comparison of groups
was performed using paired t test, and one-way ANOVAwith
post hoc Bonferroni correction was used for multiple compar-
isons. A value of P,0.05 was considered to indicate statistical
significance.We usedGraphPad prism 5 software for statistical
analysis. Further detailed descriptions on the experimental
methods are provided in the supplemental appendix 1.
RESULTS
CaOx Crystal Cytotoxicity Involves MPT
First, we evaluatedmitochondrial structure and function upon
exposure to CaOx crystals and silica, in vitro. Both induced
mitochondrial swelling, loss of cristae, loss of mitochondrial
outer membrane potential, and release of ROS with subse-
quent cell necrosis (Figure 1, A–D). The cyclophilin (and
hence MPT) inhibitor cyclosporin A fully reversed the
membrane potential, whereas ROS inhibition with APDC
did not (Figure 1E), indicating that ROS release is downstream
of losing the mitochondrial membrane potential. In support
of this finding, cyclosporin A and APDC both abrogated crys-
tal-induced ROS production and cell necrosis (Figure 1, F and
G). Similar results were obtained upon PPIF suppression with
specific siRNA (Supplemental Figure 1, A and B) in L929 cells,
as well as in primary tubular epithelial cells isolated from wild-
type and Ppif-deficient mice (Supplemental Figure 1, C and D).
Similar results were obtained for crystals of MSU and CPPD
(Supplemental Figures 1–3), implying that these effects relate
JASN 30: ccc–ccc, 2019 CYPD in Crystal Cytotoxicity 3
www.jasn.org BASIC RESEARCH
to particle structure rather than to the molecular type of crys-
tal. Thus, crystal-related cell necrosis involves MPTwith PPIF-
driven loss of the mitochondrial outer membrane potential
and ROS release as up- and downstream events, respectively.
Crystal-Induced MPT Involves Crystal Phagocytosis and
Lysosomal Leakage of Cathepsins
CaOx crystal phagocytosis, lysosomal destabilization, and
leakage of lysosomal proteases such as cathepsins are involved
in CaOx crystal–induced activation of the NLRP3 inflamma-
some and other cytosolic signaling pathways.7,21,22 Indeed,
two-dimensional (2D) transmission electron microscopy
(TEM) and 3D SB-EM imaging studies documented phago-
cytosis of large amounts of CaOx crystals into endosomal com-
partments (Figure 2, A–C, Supplemental Videos 1 and 2). The
2D confocal microscopy documented crystal uptake into lyso-
somes and loss of TMRE positivity as a marker of an intact mi-
tochondrial outer membrane potential (Figure 2, D and E).
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Figure 1. Crystal exposure leads to Ppif-dependent mitochondrial damage, subsequent ROS generation, and cell necrosis. (A–D) Crystals of
CaOx and silica were incubated with L929 cells for 24 hours as indicated. (A) TEM images show that these crystals induce mitochondrial
damage as indicated by loss of cristae and presence of swollen mitochondria (scale bar 250 nm). (B) Mitochondrial outer membrane potential
(MOMP) was measured using TMRE dye. Images show loss of membrane potential upon exposure to crystals (scale bar 25 mm). (C) ROS was
quantified using 2’,7’-dichlorodihydrofluorescein diacetate (DCFDA) dye. Images show the exposure of crystals leads to the generation of ROS
(scale bar 25 mm). (D) Cell necrosis was measured using calcein for live cells (green) and PI for dead cells (red). Images indicate cellular necrosis
upon crystal exposure (scale bar 25 mm). (E–G) Cells were pretreated with cyclosporine A (CsA) (1 mM) and antioxidant ammonium pyrrolidine
dithiocarbamate (APDC; 200 mM) before exposing to crystals. After 24 hours, (E) MOMP and (F) ROS were quantified using TMRE and DCFDA
positivity, respectively. (G) Cell necrosis was quantified using propidium iodide positivity. Results were expressed as mean fluorescence in-
tensity (MFI) on digital analysis of pictures taken from culture dishes (n=10–12). Data are representative of three independent experiments. Data
were analyzed using one-way ANOVA and are presented as mean6SEM. *P,0.05; ***P,0.001. n.s, not significant versus vehicle.
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Consistently, cytochalasin D, a phagocytosis inhibitor, par-
tially prevented the CaOx crystal–induced loss of the TMRE
signal and substantially suppressed ROS production and cell
necrosis (Figure 2, F–H). Furthermore, the cathepsin inhib-
itor CA074Me prevented CaOx crystal–induced loss of mi-
tochondrial outer membrane potential, ROS production,
and cell necrosis (Figure 2, F–H). Similar data were obtained
for MSU and CPPD crystals (Supplemental Figures 4 and 5).
Therefore, we conclude that CaOx crystal uptake via phago-
cytosis into intracellular lysosomes promotes lysosom-
al cathepsin leakage as upstream events in crystal-induced
MPT-regulated necrosis.
Ppif Deficiency Attenuates CaOx Crystal–Induced AKI
To mimic hyperoxaluria-related AKI, we exposed mice to in-
traperitoneal sodium oxalate inducing intrarenal CaOx crystal
deposition and AKI.7,8,23 CaOx crystal plugs formed within
proximal and distal tubules as evident from Pizzolato and
hematoxylin and eosin stains, as well as ex vivo kidney micro-
computed tomography (Figure 3, A–C, Supplemental Figure 6, A
and B, Supplemental Video 3) and induced TUNEL+ cytotox-
icity in proximal and distal tubules and sporadically also in col-
lecting ducts (Supplemental Figure 7). The 3D reconstruction of
SB-EM sections revealed large luminal crystal plugs and smaller
crystals also within epithelial cells of the thick ascending limb of
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Figure 2. Phagocytosis of crystals and subsequent lysosome rupture precedes crystal-induced mitochondrial damage and cell ne-
crosis. (A) 2D TEM images show different sizes and shapes of crystals of CaOx (scale bar 250 nm) and silica (scale bar 2 mm). (B–D)
Crystals of CaOx and silica were incubated with L929 cells for 24 hours as indicated. (B) TEM images indicate crystal phagocytosis. Note
that the crystals present within cells were washed out during processing, leaving behind voids in the cytosol. Some silica crystals can
still be seen. (C) A 3D reconstruction from SB-EM images shows crystals phagocytosis (yellow) placed into a context of a cell (green) and
its nucleus (blue); scale bar 5 mm. (D and E) Calcein staining reveals black spots inside cells, suggesting crystal phagocytosis. (D) Cells
were costained with lysotracker to visualize lysosomes (red). Images show colocalization of lysosomes (red) and phagosomes (black
spots in green), indicating phagolysosomes. (E) Cells were costained with TMRE (red) to access mitochondrial outer membrane po-
tential (MOMP). Images show that exposure of crystals results in loss of MOMP, indicating mitochondrial damage. (F–H) Cells were
pretreated with the phagocytosis inhibitor cytochalasin D (CytD) (10 mM) and the cathepsin inhibitor CA074Me (20 mM) before ex-
posing to crystals. After 24 hours, (F) MOMP and (G) ROS were quantified using TMRE and 2’,7’-dichlorodihydrofluorescein diacetate
(DCFDA) positivity, respectively. (H) Cell necrosis was quantified using propidium iodide positivity. Results were expressed as mean
fluorescence intensity (MFI) on digital analysis of pictures taken from culture dishes (n=10–12). Data are representative of three in-
dependent experiments. Data were analyzed using one-way ANOVA and are presented as mean6SEM. *P,0.05; ***P,0.001. n.s, not
significant versus vehicle.
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the outer medulla (Figure 3D). In contrast to unaffected tubu-
lar segments, crystal-exposed epithelial cells exhibited mito-
chondrial ballooning (Figure 3, E and F). High-resolution
TEM of such cells revealed loss of inner membrane cristae
beyond ballooning as ultrastructural signs of MPT, water in-
flux, and mitochondrial dysfunction (Figure 3, G–I). Indeed,
advanced mitochondrial abnormalities were often seen in cells
undergoing disintegration and detachment from the tubular
basement membrane (Supplemental Figure 6C), i.e., acute tu-
bular necrosis. To test whether Ppif and MPT contributes to
crystalline AKI, we induced oxalate nephropathy in wild-type
and Ppif-deficient mice, which resulted in identical CaOx crys-
tal deposits in both mouse strains (Figure 4A). Functional pa-
rameters of crystalline AKI (i.e., plasma creatinine levels) and
structural parameters of kidney injury (i.e., tubular necrosis
and TUNEL-positive cells) were significantly attenuated in
Ppif-deficient mice (Figure 4, B–E). Thus, CaOx crystal–
induced cell necrosis involves Ppif-drivenMPT-RNalso in vivo.
MPT-RN and Necroptosis Both Contribute to CaOx
Crystal Cytotoxicity In Vivo
To test for redundancy versus synergy between crystal-induced
MPT-RN and necroptosis in oxalate crystal-induced AKI, we
induced disease inmicewith single versus dual genetic deletion
of Ppif and Mlkl. Oxalate exposure induced equal amounts of
CaOx crystal deposits in all mouse strains (Figure 4A). Lack of
Mlkl showed a similar protection from AKI and tubular injury
as compared with lack of Ppif (Figure 4, B–E). Dual gene de-
ficiency for Ppif and Mlkl revealed a significant additive effect
on tubular injury compared with the single gene deficiencies;
however, this did not translate to other end points such as
plasma creatinine levels or the number of TUNEL-positive
cells (Figure 4, B–E). We conclude that crystal-induced
tissue injury involves PPIF and MLKL, suggesting that both
MPT-RN and necroptosis are involved. In addition, their par-
tially redundant roles in crystalline AKI imply a collaborative
interaction of these two signaling pathways in vivo.
MPT-RN and Necroptosis-Targeted Pharmaceutical
Interventions Abrogate Crystalline Organ Injury and
Failure
To test whether PPIF could be amolecular target for therapeu-
tic intervention and to determine the potential of dual
MPT-RN/necroptosis blockade, we treated wild-type mice
with the MPT inhibitor cyclosporin A, the necroptosis inhib-
itor necrostatin-1s, or both. Oxalate exposure induced equal
amounts of renal CaOx crystal deposits in mice of all groups
(Figure 5A). Cyclosporin A and necrostatin-1s had compara-
ble partial renoprotective effects on plasma creatinine levels
as a marker of AKI and on tubular injury and the number of
TUNEL-positive cells (Figure 5, B–E). Dual blockade was
more potent than either monotherapy, especially in terms of
AKI and TUNEL positivity (Figure 5, B–E). Thus, dual inhi-
bition of MPT- and MLKL-driven necroptosis can elicit
some additive effects on crystalline organ failure, but also
this experiment supports functional overlap between the
two pathways in vivo.
MPT in Human Tubular Cells and Acute Oxalate
Nephropathy
To validate ourmouse data in humans, we performed identical
experiments on crystal cytotoxicity inHK-2 cells and obtained
results identical to those generated with murine cells (Supple-
mental Figure 8). Then, we used CD24/CD133-positive
epithelial progenitor cells isolated from healthy human
kidneys, known to contribute to the turnover of tubular epi-
thelial cells and their regeneration upon injury.13,24 For all
crystals tested, the results were identical to the murine cells
examined before (Figure 6A, Supplemental Figure 9). Next, we
searched a database of 92,000 diagnostic kidney biopsies and
identified 1262 cases (1.4%) showing CaOx crystals deposits
by light microscopy and birefringence under polarized light.
A total of 553 of these 1262 specimens (44%, or 0.6% of total)
showed CaOx crystals in the context of acute tubular injury.
Furthermore, immunostaining of renal tissue from oxalosis-
induced AKI revealed diffuse tubular positivity for PPIF
and focal positivity for phosphorylated MLKL in injured cells
(Figure 6, B–E). Thus, we conclude that crystal-induced cyto-
toxicities of human and murine kidney cells are similar and
that human tubular epithelial cells also express CYPD and
activated MLKL in the context of oxalate crystal-induced AKI.
DISCUSSION
We had previously shown that CaOx crystal cytotoxicity is
caspase-independent, and therefore does not involve apo-
ptosis, but rather regulated necrosis.8 However, as interfer-
ing with necroptosis had been only partially protective, we
had hypothesized that crystal cytotoxicity might involve
additional pathways of regulated necrosis.9 Indeed, CaOx
crystal cytotoxicity involves phagocytosis and subsequent
lysosomal leakage upstream of PPIF-dependent mitochon-
drial dysfunction, followed by ROS production and necrotic
cell death, as previously reported for MPT-RN.9 Consis-
tently, we found PPIF-dependent MPT-RN to contribute
to oxalate crystal-induced AKI. However, the lack of robust
additive effects with either dual genetic deficiency or inhi-
bition of the both pathways in vivo implies a molecular
interference and partial redundancy of these two pathways
in vivo in our oxalate-induced AKI. These data further unravel
the molecular pathophysiology of hyperoxaluria-related AKI
and identify PPIF as another potential molecular target to limit
kidney injury in this context.
Mitochondrial proteins in the outer or innermitochondrial
membranes have been ascribed important roles in the regula-
tion of inflammation and cell death.9,25,26 MPT-RN is
controlled by PPIF, a mitochondrial matrix protein that is
thought to promote the opening of MPT pores. This mecha-
nism drives the breakdown of the mitochondrial outer
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Figure 3. Acute oxalate nephropathy involves mitochondrial damage in tubular epithelial cells leading to acute tubular necrosis.
(A) Pizzolato staining reveals no crystal deposition in control mice, (B) whereas the presence of diffuse intrarenal crystals in mice
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membrane potential, water influx, mitochondrial swelling,
loss of cristae, massive ROS production, and ultimately, mi-
tochondrial and cellular demise.9,25 The biologic significance
of this process was documented in several disease contexts
by using Ppif-deficient mice and small molecule PPIF
inhibitors.12,27,28 In particular, postischemic or radio contrast
medium–induced AKI involves PPIF-driven MPTand regu-
lated necrosis,29,30 although the specific triggers of PPIF ac-
tivation remained elusive. Our data now demonstrate that
CaOx crystal phagocytosis exerts a direct PPIF-driven
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Figure 4. Both MPT-induced regulated necrosis and necroptosis contribute to crystalline AKI. (A) Oxalate feeding to wild-type mice as
well as to Ppif- and Mlkl-deficient, and Ppif/Mlkl double-deficient mice, of the same genetic background, resulted in identical amounts
of CaOx crystal deposition after 24 hours as quantified by morphometry of Pizzolato-stained kidney sections. (B–D) Oxalate ne-
phropathy in wild-type mice was associated with increased (B) plasma creatinine, (C) tubular injury, and (D) TUNEL positive cells, which
were attenuated in the gene-deficient mouse strains. PAS staining illustrated tubular necrosis at the corticomedullary junction in wild-
type mice. Original image magnification: 3100 (E). TUNEL staining identified dying cells (red), with counterstaining for laminin (green)
and cell nuclei (DAPI, white). Original image magnification: 3200 (F). Data are means6SEM from six to nine mice in each group. Data
were analyzed using one-way ANOVA with post hoc Bonferroni correction and are presented as mean6SEM. *P,0.05; ***P,0.001
versus oxalate-treated wild-type mice. C, cortex; ISOM, inner stripe of outer medulla; OSOM, outer stripe of outer medulla.
exposed to oxalate, (C) which is further confirmedby ex vivo kidney computed tomography. Scalebar in (A andB) 50mm. (D) SB-EMand3D
reconstruction of a mouse kidney with oxalate nephropathy shows a intact segment of (E) a distal tubule and (F) a segment of the same
tubule obstructed segment by a crystal plug. A larger magnification of the left frame (E) shows numerous normal-shaped mitochondria
(white arrows) at the basolateral aspect of intact distal tubular epithelial cells. In contrast, a largermagnification of the right frame (F) shows
tubule cells exposed to a crystal plug (asterisk) in the tubule lumen as well as numerous intracellular crystals (black arrows) in spatial as-
sociation to enlarged mitochondria (white arrows) and signs of cell disintegration. Scale bar (E and F) 5 mm. TEM shows the presence of
healthy mitochondria in control mice (H) and damagedmitochondria, as seen by loss of cristae, the presence of lucent matrix, and swollen
mitochondria (white arrows) in proximity to intrarenal crystals in mice exposed to oxalate (G and I). Scale bar (G) 1 mm, (H and I) 250 nm.
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cytotoxic effect, MPT-related regulated necrosis, on tubular
epithelial cells in culture. In mice, this process contributes to
oxalate crystal-induced acute tubular necrosis and crystal-
line AKI independent of CaOx crystallization per se, as pre-
viously reported.11,31 In acute oxalate nephropathy, this
mechanism adds onto MLKL-driven necroptosis and
NLRP3-driven interstitial inflammation, i.e., other molecular
pathways directly triggered by crystalline particles within the
kidney.1,7,8 Thus, hyperoxaluria-related AKI presents numer-
ous molecular targets to attenuate organ failure.
The role ofmitochondria in CaOxcrystal cytotoxicity raises
questions on the causative upstream and downstream signals.
Our 2D and 3D analysis revealed that even non-professional
phagocytes take up CaOx crystals and other microparticles into
intracellular endosomal compartments. Indeed, blocking CaOx
crystal uptake prevents the loss of themitochondrial outermem-
brane potential, ROS production, and necrosis, suggesting
CaOx crystal phagocytosis as an upstream event of MPT-related
regulated necrosis. Crystalline microparticles are difficult to di-
gest inside phagolysosomes and may cause lysosomal leakage
of proteases, a process well described to contribute to crystal-
induced activationof theNLRP3 inflammasome.7,32 In addition,
one study indicated that the cysteine cathepsins might cleave
RIPK1, an endogenous inhibitor of necroptosis.33 Indeed, we
observed that cathepsin inhibition partially prevented CaOx
crystal–induced MPT-related regulated necrosis.
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Figure 5. Cyclosporin A and necrostatin-1s abrogate crystal nephropathy. (A–D) Oxalate exposure to wild-type mice treated
with vehicle, the MPT inhibitor cyclosporine A (CsA; 2 mg/kg), RIP1 kinase inhibitor necrostatin-1s (Nec-1s), or combination of CsA with
Nec-1s resulted in (A) identical amounts of CaOx crystal deposition after 24 hours as quantified by morphometry of Pizzolato-stained
kidney sections but significantly reduced (B) the levels of plasma creatinine, (C) tubular injury, and (D) the number of TUNEL-positive
cells in kidney sections. (E) PAS staining illustrated tubular necrosis at the corticomedullary junction in wild-type mice. Original image
magnification: 3100 (E upper panel). TUNEL staining identified dying cells (red), with counterstaining for laminin (green) and cell nuclei
(DAPI, white). Original image magnification: 3200 (E lower panel). Data are means6SEM from five to seven mice in each group. Data
were analyzed using one-way ANOVA with post hoc Bonferroni correction. *P,0.05; **P,0.01; ***P,0.001 versus vehicle-treated
mice. C, cortex; ISOM, inner stripe of outer medulla; OSOM, outer stripe of outer medulla.
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Figure 6. Mitochondria permeability transition-related necrosis and necroptosis in human acute oxalate nephropathy. (A) Primary renal
human progenitor cells were pretreated with vehicle, CsA (1 mM), APDC (200 mM), CytD (10 mM), and CA074Me (20 mM) before being
exposed to CaOx (1000 mg/ml) and silica (250 mg/ml). Cell necrosis was quantified using propidium iodide positivity. Results were
expressed as mean fluorescence intensity (MFI) on digital analysis of pictures taken from culture dishes (n=3–4). Data are representative
from three independent experiments. Data were analyzed using one-way ANOVA and are presented as mean6SEM. ***P,0.001
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The signaling events downstream ofMPTare less clear. The
release of ROS from mitochondria is considered an essential
step in MPT-related regulated necrosis.9,25 However, it is
clear that widespread depletion of mitochondria in cell cul-
ture does not affect the kinetics of necroptosis.34 However,
it is appreciated that data have been published on MLKL-
driven necroptosis that involves mitochondrial transloca-
tion of pMLKL in certain culture conditions.35–37 As we
found that a dual genetic deficiency of Ppif or Mlkl did not
give consistent results across all aspects of AKI, we conclude
that at least in hyperoxaluria-induced AKI tested here,
MPT-related regulated necrosis and necroptosis are not in-
dependent and both involve mitochondrial dysfunction in
the context of AKI. Indeed, a recent heart transplant study
reported MLKL phosphorylation and necroptosis down-
stream of PPIF activation.38 Although dual deficiency of
PPIF or MLKL elicited the most potent protective effect on
tubular injury, the combinations of two cell death inhibitors
with doubtful specificities did not. These data do not exclude
independent roles of the both pathways in acute oxalosis,
but are consistent with a significant interference of both
pathways in crystal cytotoxicity. This finding would be in
line with the concept of some redundancy between signaling
pathways of regulated necrosis in AKI.39
In conclusion, crystal cytotoxicity involves mitochondrial
dysfunction and MPT-related regulated necrosis as a form of
versus vehicle. (B–E) Serial sections from human biopsies with oxalate crystal-induced AKI were stained with hematoxylin and eosin and
visualized using (B) bright-field microscopy and (C) under polarization. (D) Serial section immunostained for PPIF and (E) immunostaining
for p-MLKL. Note the oxalate crystals in consecutive sections marked with white arrows in (C) and with the topmost and the bottom black
arrow in (B). Flattened tubular epithelial cells aremarkedwith the black arrow in themiddle in (B). Tubular lumina aremarkedwith asterisks
in (B). Also, note the diffuse staining of tubular epithelial cells for PPIF (brown) in (D) and the punctate cytoplasmic staining for p-MLKL
(brown) in the insert in (E). Original magnification: 3400 for all images, scale bar in (A) represents 20 mm.
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regulated cell death in cell culture andmouse models (Figure 7).
Consequently, targeting this pathway, for example, with cyclo-
sporine A, which may have anti-inflammatory capacities be-
yond inhibition of MPT, may prevent crystal-induced tissue
necrosis and organ dysfunction. As interconnections to
MLKL-driven necroptosis appear functionally likely, combina-
tions of necrosis inhibitors may exhibit some additive
effects, but this needs to be further explored in other
crystallopathies.
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